Go Pro
NYSEARCA:IDNA

iShares Genomics Immunology and Healthcare ETF (IDNA) Price, Holdings, & News

iShares Genomics Immunology and Healthcare ETF logo
$41.77 +0.08 (+0.19%)
Closing price 09/25/2026 04:10 PM Eastern
Extended Trading
$41.20 -0.57 (-1.35%)
As of 09/25/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)

Advanced

Key Stats

Today's Range
$41.21
▼
$41.83
50-Day Range
$32.03
▼
$41.77
52-Week Range
$22.38
▼
$41.86
Volume
61,819 shs
Average Volume
58,485 shs
Market Capitalization
$284.04 million
Assets Under Management
$287.21 million
Dividend Yield
0.67%
Net Expense Ratio
0.47%
Aggregate Rating
Moderate Buy

ETF Overview

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.

iShares Genomics Immunology and Healthcare ETF Expenses

TypeIDNATheme ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.47%0.57%0.57%0.50%0.53%
Other Expenses0.00%0.57%0.53%0.60%0.54%
Total Expense0.47%0.72%0.75%0.75%0.73%
Fee Waiver0.00%-0.72%-0.67%-0.78%-0.68%
Net Expense0.47%0.60%0.63%0.57%0.60%
Receive IDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IDNA ETF News Headlines

(IDNA) iShares Genomics Immunology and Healthcare ETF
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
IDNA: 3 Catalysts To Watch Closely
iShares Genomics Immunology & Healthcare ETF
See More Headlines

IDNA ETF - Frequently Asked Questions

iShares Genomics Immunology and Healthcare ETF's stock was trading at $26.19 on January 1st, 2026. Since then, IDNA shares have increased by 59.5% and is now trading at $41.77.

Top institutional shareholders of iShares Genomics Immunology and Healthcare ETF include Anchor Investment Management LLC (0.05%) and NewEdge Advisors LLC (0.02%).

Shares of IDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Genomics Immunology and Healthcare ETF investors own include iShares Micro-Cap ETF (IWC), The RMR Group (RMR), Waste Connections (WCN), DiamondRock Hospitality (DRH), AUO (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

Fund Details

Issuer
iShares
Fund Name
iShares Genomics Immunology and Healthcare ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:IDNA
Inception Date
6/11/2019
Fund Manager
Jennifer Hsui, Greg Savage, Paul Whitehead
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NYSE FactSet Global Genomics and Immuno Biopharma Index
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
63

Fund Statistics

Assets Under Management
$287.21 million
Average Daily Volume
$0.00
Discount/Premium
0.15%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
BlackRock Fund Advisors
Custodian
State Street Bank and Trust Company
Distributor
BlackRock Investments, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
Optionable
Options Volume
2
Put Options
2
Call Options
0
Short Interest
23,081 shs

Miscellaneous

Beta
0.95
Creation Unit
50,000
Creation Fee
$850.00
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Top 10 IDNA Holdings

IDNA Sector Exposure

IDNA Industry Exposure


This page (NYSEARCA:IDNA) was last updated on 9/27/2026 by MarketBeat.com Staff.
From Our Partners